Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Research Areas
Products Related to Obesity, Appetite Control & Diabetes(354)
- GC52390Spexin 1 (human, mouse, rat, bovine) (acetate)Purity: >98.00%
An endogenous peptide and agonist of GAL 2 and GAL 3
- GC5239810-oxo-12(Z)-Octadecenoic Acid ethyl esterPurity: >95.00%
An ester form of 10-oxo-12(Z)-octadecenoic acid
- GC5242810-oxo-12(Z)-Octadecenoic Acid-d5Purity: >99.00%
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid
- GC52453Orexin A (17-33) (human, mouse, rat, bovine) (trifluoroacetate salt)Purity: >98.00%
A peptide orexin receptor 1 agonist
- GC52504Human Vitamin D Receptor Reporter Assay SystemPurity: >98%
A nuclear receptor cell-based reporter assay
- GC52507Orexin A amide (bovine, human, mouse, rat) (trifluoroacetate salt)Purity: >95.00%
A hypothalamic neuropeptide
- GC60871Gemigliptin tartrateCAS: 1374639-74-3Purity: >98.00%
Gemigliptintartrat (LC15-0444-Tartrat) ist ein hochselektiver, reversibler und kompetitiver Dipeptidylpeptidase-4 (DPP-4)-Inhibitor mit einem IC50-Wert von 10,3 nM fÜr humanes rekombinantes DPP-4.
- GC60997Lixisenatide acetateCAS: 1997361-87-1Purity: >98.50%
Lixisenatidacetat ist ein Glucagon-like Peptide-1 (GLP-1)-Rezeptoragonist, der zur Behandlung von Typ-2-Diabetes mellitus (T2DM) eingesetzt werden kann.
- GC69439MazdutideCAS: 2259884-03-0Purity: >99.00%
Mazdutide (IBI-362; LY-3305677) is a long-acting synthetic gastrin-releasing peptide analog. Mazdutide is also a co-agonist of glucagon-like peptide 1 receptor (GLP-1R) and glucagon receptor (GCGR). Mazdutide has safety and tolerability, and can be used in the study of obesity and type 2 diabetes (T2D).
- GC70855LSN3318839CAS: 2764704-18-7Purity: >99.00%
LSN3318839 ist ein oral wirksamer positiver allosterischer Modulator des glukagonähnlichen Peptid-1 Rezeptors (GLP-1R).
- GC72096BamadutideCAS: 1596343-09-7Purity: >99.00%
Bamadutide (SAR25899) ist ein potenter dualer Glucagon-ähnlicher Peptid-1-Rezeptor/Glucagon-Rezeptor-Agonist.
- GC72222SurvodutideCAS: 2805997-46-8Purity: >99.50%
Survodutide (BI 456906) ist ein potenter, selektiver Glukagonrezeptor/GLP-1 Rezeptor (GCGR/GLP-1R) Doppelagonist mit EC50s von 0,52 nM bzw. 0,33 nM in CHO-K1 Zellen.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC52388 | [D-Lys3]-GHRP-6 (trifluoroacetate salt) | - | >95.00% | |
An antagonist of GHS-R1a | ||||
| GC52390 | Spexin 1 (human, mouse, rat, bovine) (acetate) | - | >98.00% | |
An endogenous peptide and agonist of GAL 2 and GAL 3 | ||||
| GC52398 | 10-oxo-12(Z)-Octadecenoic Acid ethyl ester | - | >95.00% | |
An ester form of 10-oxo-12(Z)-octadecenoic acid | ||||
| GC52428 | 10-oxo-12(Z)-Octadecenoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid | ||||
| GC52453 | Orexin A (17-33) (human, mouse, rat, bovine) (trifluoroacetate salt) | - | >98.00% | |
A peptide orexin receptor 1 agonist | ||||
| GC52476 | Bax Inhibitor Peptide V5 (trifluoroacetate salt) | - | >98.00% | |
A Bax inhibitor | ||||
| GC52490 | Glucagon (hydrochloride) | 19179-82-9 | >95.00% | |
A peptide hormone | ||||
| GC52493 | Glucosylceramide (bovine buttermilk) | - | >98.00% | |
A sphingolipid | ||||
| GC52496 | Sulfatide (bovine) (sodium salt) | - | >95.00% | |
A mixture of isolated bovine sulfatides | ||||
| GC52497 | Lactosylceramide (porcine RBC) | - | >98.00% | |
A sphingolipid | ||||
| GC52502 | Peptide YY (3-36) (trifluoroacetate salt) | - | >95.00% | |
A satiety hormone | ||||
| GC52504 | Human Vitamin D Receptor Reporter Assay System | - | >98% | |
A nuclear receptor cell-based reporter assay | ||||
| GC52506 | Ghrelin (human) (trifluoroacetate salt) | - | >98.00% | |
A growth hormone releasing peptide | ||||
| GC52507 | Orexin A amide (bovine, human, mouse, rat) (trifluoroacetate salt) | - | >95.00% | |
A hypothalamic neuropeptide | ||||
| GC60311 | PTUPB | 1287761-01-6 | >98.00% | |
PTUPB ist ein potenter und dualer sEH- und COX-2-Enzyminhibitor mit IC50 von 0,9 nM bzw. 1,26 μM. | ||||
| GC60871 | Gemigliptin tartrate | 1374639-74-3 | >98.00% | |
Gemigliptintartrat (LC15-0444-Tartrat) ist ein hochselektiver, reversibler und kompetitiver Dipeptidylpeptidase-4 (DPP-4)-Inhibitor mit einem IC50-Wert von 10,3 nM fÜr humanes rekombinantes DPP-4. | ||||
| GC60997 | Lixisenatide acetate | 1997361-87-1 | >98.50% | |
Lixisenatidacetat ist ein Glucagon-like Peptide-1 (GLP-1)-Rezeptoragonist, der zur Behandlung von Typ-2-Diabetes mellitus (T2DM) eingesetzt werden kann. | ||||
| GC64119 | Saponarin | 20310-89-8 | >98% | |
Saponarin ist ein aus Gypsophila trichotoma isoliertes natÜrliches Flavonoid mit antioxidativer, entzÜndungshemmender und hepatoprotektiver Wirkung. | ||||
| GC69439 | Mazdutide | 2259884-03-0 | >99.00% | |
Mazdutide (IBI-362; LY-3305677) is a long-acting synthetic gastrin-releasing peptide analog. Mazdutide is also a co-agonist of glucagon-like peptide 1 receptor (GLP-1R) and glucagon receptor (GCGR). Mazdutide has safety and tolerability, and can be used in the study of obesity and type 2 diabetes (T2D). | ||||
| GC70855 | LSN3318839 | 2764704-18-7 | >99.00% | |
LSN3318839 ist ein oral wirksamer positiver allosterischer Modulator des glukagonähnlichen Peptid-1 Rezeptors (GLP-1R). | ||||
| GC72096 | Bamadutide | 1596343-09-7 | >99.00% | |
Bamadutide (SAR25899) ist ein potenter dualer Glucagon-ähnlicher Peptid-1-Rezeptor/Glucagon-Rezeptor-Agonist. | ||||
| GC72222 | Survodutide | 2805997-46-8 | >99.50% | |
Survodutide (BI 456906) ist ein potenter, selektiver Glukagonrezeptor/GLP-1 Rezeptor (GCGR/GLP-1R) Doppelagonist mit EC50s von 0,52 nM bzw. 0,33 nM in CHO-K1 Zellen. | ||||
| GC90363 | 10(11)-Cl-BBQ | - | >95.00% | |
Eine Mischung, die als AhR-Agonist wirkt. | ||||
| GC90496 | β-Cortolone | 667-66-3 | >95.00% | |
Ein Stoffwechselprodukt von Cortisol. | ||||